Last reviewed · How we verify
Blood, nasopharyngeal swab and saliva — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Blood, nasopharyngeal swab and saliva (Blood, nasopharyngeal swab and saliva) — Ming-Yuan Chen.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Blood, nasopharyngeal swab and saliva TARGET | Blood, nasopharyngeal swab and saliva | Ming-Yuan Chen | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Blood, nasopharyngeal swab and saliva CI watch — RSS
- Blood, nasopharyngeal swab and saliva CI watch — Atom
- Blood, nasopharyngeal swab and saliva CI watch — JSON
- Blood, nasopharyngeal swab and saliva alone — RSS
Cite this brief
Drug Landscape (2026). Blood, nasopharyngeal swab and saliva — Competitive Intelligence Brief. https://druglandscape.com/ci/blood-nasopharyngeal-swab-and-saliva. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab